Escherichia coli (DSM 103538, ATCC 700928, CFT073)
BacDive ID
131713
Type strain
Strain Designation
CFT073
NCBI tax ID(s)
562
History
DSMZ <- U. Dobrindt, Univ. Münster, Germany; CFT073 <- H. L. T. Mobley, University of Michigan Medical School, Ann Arbor <- H. L. T. Mobley, University of Maryland Hospital, Baltimore
Links
Escherichia coli CFT073 is a human pathogen that was isolated from Human clinical specimen - blood and urine from a woman with acute pyelonephritis.
human pathogen genome sequence BacteriaName and taxonomic classification
| @ref 20215 |
|
Last LPSN update
2026-05-29 08:37:41 |
| Domain Bacteria |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Enterobacterales |
| Family Enterobacteriaceae |
| Genus Escherichia |
| Species Escherichia coli |
| Full scientific name Escherichia coli (Migula 1895) Castellani and Chalmers 1919 (Approved Lists 1980) |
| Synonyms (1) |
Culture and growth conditions
Culture medium
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 23509 | TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) | Medium recipe at MediaDive  | Name: TRYPTICASE SOY YEAST EXTRACT MEDIUM (DSMZ Medium 92) Composition: Trypticase soy broth 30.0 g/l Agar 15.0 g/l Yeast extract 3.0 g/l Distilled water | ||
| 23509 | LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) | Medium recipe at MediaDive | Name: LB (Luria-Bertani) MEDIUM (DSMZ Medium 381) Composition: Agar 20.0 g/l NaCl 10.0 g/l Tryptone 10.0 g/l Yeast extract 5.0 g/l Distilled water |
Culture temp
| @ref | Growth | Type | Temperature (°C) | |
|---|---|---|---|---|
| 23509 | positive | growth | 37 |
Physiology and metabolism
Oxygen tolerance
| @ref | Oxygen tolerance | Confidence | |
|---|---|---|---|
| 125439 | aerobe | 91.561 |
Antibiotic susceptibility testing
| Test 1 | |
|---|---|
| @ref | 23509 |
| Medium | Müller-Hinton Agar |
| Manual annotation | 1 |
| Inhibition zone diameter in mm | |
| Amikacin 30µg (disc) | 24 |
| Ampicillin 10µg (disc) | 22 |
| Aztreonam 30µg (disc) | 36-38 |
| Cefiderocol 30µg (disc) | 38 |
| Cefotaxime 30µg (disc) | 38 |
| Ceftazidime 10µg (disc) | 30 |
| Ceftriaxone 30µg (disc) | 38-40 |
| Chloramphenicol 30µg (disc) | 30 |
| Ciprofloxacin 5µg (disc) | 46 |
| Clindamycin 10µg (disc) | 0 |
| Colistin sulphate 10µg (disc) | 16-18 |
| Erythromycin 15µg (disc) | 8 |
| Fosfomycin 50µg (disc) | 30 |
| Gentamicin 30µg (disc) | 24-26 |
| Imipenem 10µg (disc) | 32 |
| Kanamycin 30µg (disc) | 24 |
| Levofloxacin 5µg (disc) | 44 |
| Linezolid 10µg (disc) | 0 |
| Meropenem 10µg (disc) | 38 |
| Moxifloxacin 5µg (disc) | 40 |
| Nitrofurantoin 100µg (disc) | 22-24 |
| Ofloxacin 5µg (disc) | 38-40 |
| Oxacillin 5µg (disc) | 0 |
| Penicillin G 6µg (disc) | 0 |
| Piperacillin/Tazobactam 110µg (disc) | 32-34 |
| Polymyxin B 300Unit | 18 |
| Quinupristin/Dalfopristin 15µg (disc) | n.d. |
| Rifampicin 5µg (disc) | 8-10 |
| Teicoplanin 30µg (disc) | 0 |
| Tetracycline 30µg (disc) | 30 |
| Ticarcillin 75µg (disc) | 32-34 |
| Tigecycline 15µg (disc) | 28 |
| Trimethoprim-sulfamethoxazole (1:19) 10µg (disc) | 32 |
| Vancomycin 30µg (disc) | 0 |
Metabolite utilization
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68368 | 17634 ChEBI | D-glucose | + | fermentation | from API 20E |
| 68368 | 16899 ChEBI | D-mannitol | + | fermentation | from API 20E |
| 68368 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20E |
| 68368 | 30849 ChEBI | L-arabinose | + | fermentation | from API 20E |
| 68368 | 62345 ChEBI | L-rhamnose | + | fermentation | from API 20E |
| 68368 | 25094 ChEBI | lysine | + | degradation | from API 20E |
| 68368 | 28053 ChEBI | melibiose | + | fermentation | from API 20E |
| 68368 | 17268 ChEBI | myo-inositol | - | fermentation | from API 20E |
| 68368 | 18257 ChEBI | ornithine | + | degradation | from API 20E |
| 68368 | 30911 ChEBI | sorbitol | + | fermentation | from API 20E |
| 68368 | 17992 ChEBI | sucrose | - | fermentation | from API 20E |
| 68368 | 27897 ChEBI | tryptophan | + | energy source | from API 20E |
| 68368 | 16199 ChEBI | urea | - | hydrolysis | from API 20E |
Antibiotic resistance
| @ref | ChEBI | Metabolite | Is resistant | Resistance conc. | |
|---|---|---|---|---|---|
| 23509 | 3745 | Clindamycin | 10 µg (disc) | from Antibiotic test | |
| 23509 | 63607 | Linezolid | 10 µg (disc) | from Antibiotic test | |
| 23509 | 7809 | Oxacillin | 5 µg (disc) | from Antibiotic test | |
| 23509 | 18208 | Penicillin G | 6 µg (disc) | from Antibiotic test | |
| 23509 | 29687 | Teicoplanin | 30 µg (disc) | from Antibiotic test | |
| 23509 | 28001 | Vancomycin | 30 µg (disc) | from Antibiotic test |
Metabolite production
Enzymes
API 20E
Sequence information
Genome sequences
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM2155985v1 assembly for Escherichia coli CFT073 | complete | GCA_021559855   | 562.94315  | 562 | 99.08 | | |
| 66792 | ASM1426294v1 assembly for Escherichia coli CFT073 | complete | GCA_014262945 | 199310.237 | 8012096689  | 199310 | 98.69 | |
| 66792 | ASM744v1 assembly for Escherichia coli CFT073 | complete | GCA_000007445 | 199310.4 | 637000105 | 199310 | 98.19 | |
| 66792 | ASM302879v1 assembly for Escherichia coli CFT073 | chromosome | GCA_003028795 | 562.29037 | 3008005312 | 562 | 70.55 | |
Genome browser: GCA_021559855
Literature
Literature 
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Non Clinical Model to Assess the Mechanism of Action of a Combined Hyaluronic Acid, Chondroitin Sulfate and Calcium Chloride: HA+CS+CaCl2 Solution on a 3D Human Reconstructed Bladder Epithelium. | Brambilla L, Frangione V, Meloni M. | Med Devices (Auckl) | 10.2147/mder.s433261 | 2024 | | |
| Carboxy-Amidated AamAP1-Lys has Superior Conformational Flexibility and Accelerated Killing of Gram-Negative Bacteria. | Van Wyk RJ, Serem JC, Oosthuizen CB, Semenya D, Serian M, Lorenz CD, Mason AJ, Bester MJ, Gaspar ARM. | Biochemistry | 10.1021/acs.biochem.4c00580 | 2025 | | |
| Antibacterial Properties of Bacteriocin Purified from Serratia marcescens and Computerized Assessment of its Interaction with Antigen 43 in Escherichia coli. | Mousavi SM, Archangi B, Zamani I. | Arch Razi Inst | 10.32592/ari.2023.78.6.2694 | 2023 | | |
| A review of the anti-bacterial effects exerted by Aronia melanocarpa. | Ghanbari SA, Mousavi S, Bereswill S, Heimesaat MM. | Eur J Microbiol Immunol (Bp) | 10.1556/1886.2024.00139 | 2025 | | |
| Antibacterial efficacy of combined atmospheric cold plasma and hydrogen peroxide treatment on a wound surrogate. | Patel PK, Mishra P, Ashour HK, Mandar NR, Mbarki S, Mao Y, Kumar S, Berthiaume F, Mazzeo AD. | Biochem Biophys Rep | 10.1016/j.bbrep.2025.102296 | 2025 | | |
| Comparison of phenotypic and genetic traits of ESBL-producing UPEC strains causing recurrent or single episode UTI in postmenopausal women. | Kalu M, Jorth P, Wong-Beringer A. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-025-00779-7 | 2025 | | |
| NRX-101 (D-Cycloserine + Lurasidone) Is Active against Drug-Resistant Urinary Pathogens In Vitro. | Sapko MT, Manyak M, Panicucci R, Javitt JC. | Antibiotics (Basel) | 10.3390/antibiotics13040308 | 2024 | | |
| Proteome | Species-Specific Stress Responses to Selenium Nanoparticles in Pseudomonas aeruginosa and Proteus mirabilis. | Sung K, Park M, Kweon O, Savenka A, Paredes A, Sadaka M, Khan S, Min S, Foley S. | Nanomaterials (Basel) | 10.3390/nano15181404 | 2025 | |
| Uropathogenic Escherichia coli (UPEC) that hides its identity: features of LC2 and EC73 strains from recurrent urinary tract infections. | Maurizi L, Musleh L, Brunetti F, Conte AL, Riccioli A, Sideri S, Ammendolia MG, Uccelletti D, Schifano E, De Angelis M, Ianiro G, Niro A, Cutone A, Conte MP, Longhi C. | BMC Microbiol | 10.1186/s12866-025-04287-8 | 2025 | | |
| Facile Modification of Medical-Grade Silicone for Antimicrobial Effectiveness and Biocompatibility: A Potential Therapeutic Strategy against Bacterial Biofilms. | Wynne KJ, Zolotarskaya O, Jarrell R, Wang C, Amin Y, Brunson K. | ACS Appl Mater Interfaces | 10.1021/acsami.3c08734 | 2023 | | |
| Uropathogenic Escherichia coli Associated with Risk of Urosepsis-Genetic, Proteomic, and Metabolomic Studies. | Krawczyk B, Wityk P, Burzynska M, Majchrzak T, Markuszewski MJ. | Int J Mol Sci | 10.3390/ijms26125681 | 2025 | | |
| Rapid formulation of a genetically diverse phage cocktail targeting uropathogenic Escherichia coli infections using the UTI89 model. | Kongsomboonchoke P, Mongkolkarvin P, Khunti P, Vijitphichiankul J, Nonejuie P, Thiennimitr P, Chaikeeratisak V. | Sci Rep | 10.1038/s41598-025-96561-y | 2025 | | |
| Iron uptake by Escherichia coli in urinary tract infections and urosepsis. | Krawczyk B, Wityk P, Laskowska A, Stanislawska-Sachadyn A, Raczak-Gutknecht J, Waszczuk-Jankowska M, Burzynska M, Bronk M, Majchrzak T, Markuszewski MJ. | PLoS One | 10.1371/journal.pone.0326251 | 2025 | | |
| Broad-Spectrum Antimicrobial and Antibiofilm Activities of Halogenated Anilines Against Uropathogenic Escherichia coli and ESKAPE Pathogens. | Boya BR, Lee JH, Lee J. | Microb Biotechnol | 10.1111/1751-7915.70165 | 2025 | | |
| UNAM-HIMFG Bacterial Lysate Activates the Immune Response and Inhibits Colonization of Bladder of Balb/c Mice Infected with the Uropathogenic CFT073 Escherichia coli Strain. | Acevedo-Monroy SE, Hernandez-Chinas U, Rocha-Ramirez LM, Medina-Contreras O, Lopez-Diaz O, Ahumada-Cota RE, Martinez-Gomez D, Huerta-Yepez S, Tirado-Rodriguez AB, Molina-Lopez J, Castro-Luna R, Martinez-Cristobal L, Rojas-Castro FE, Chavez-Berrocal ME, Verdugo-Rodriguez A, Eslava-Campos CA. | Int J Mol Sci | 10.3390/ijms25189876 | 2024 | | |
| Pathogenicity | TLR2 and NLRP3 Orchestrate Regulatory Roles in Escherichia coli Infection-Induced Septicemia in Mouse Models. | Gong Z, Mao W, Zhao J, Ren P, Yu Z, Bai Y, Wang C, Liu Y, Feng S, Hasi S. | J Innate Immun | 10.1159/000541819 | 2024 | |
| Impact of Escherichia coli Outer Membrane Vesicles on Sperm Function. | Folliero V, Santonastaso M, Dell'Annunziata F, De Franciscis P, Boccia G, Colacurci N, De Filippis A, Galdiero M, Franci G. | Pathogens | 10.3390/pathogens11070782 | 2022 | | |
| Purified alpha-Amylase from Bacillus cereus exhibits antibiofilm and antiquorum sensing activities against uropathogenic Escherichia coli, Downregulating fimH, and papC virulence genes: implications for urinary tract infections. | Abo-Kamar AM, Mustafa AA, Al-Madboly LA. | BMC Microbiol | 10.1186/s12866-024-03542-8 | 2024 | | |
| The PapB/FocB family protein TosR acts as a positive regulator of flagellar expression and is required for optimal virulence of uropathogenic Escherichia coli. | Hirakawa H, Shimokawa M, Noguchi K, Tago M, Matsuda H, Takita A, Suzue K, Tajima H, Kawagishi I, Tomita H. | Front Microbiol | 10.3389/fmicb.2023.1185804 | 2023 | | |
| Therapeutic Effects of DNase I on Peripheral and Local Markers of Liver Injury and Neutrophil Extracellular Traps in a Model of Alcohol-Related Liver Disease. | Belvoncikova P, Fejes A, Gromova B, Janovicova L, Farkasova A, Babal P, Gardlik R. | Int J Mol Sci | 10.3390/ijms26051893 | 2025 | | |
| A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections. | Sereme Y, Schrimp C, Faury H, Agapoff M, Lefebvre-Wloszczowski E, Chang Marchand Y, Ageron-Ardila E, Panafieu E, Blec F, Coureuil M, Frapy E, Tsatsaris V, Bonacorsi S, Skurnik D. | Nat Commun | 10.1038/s41467-024-46775-x | 2024 | | |
| Novel drug candidates against antibiotic-resistant microorganisms: A review. | Lim JS, Chai YY, Ser WX, Haeren AV, Lim YH, Raja T, Foo JB, Hamzah S, Sellappans R, Yow HY. | Iran J Basic Med Sci | 10.22038/ijbms.2023.71672.15593 | 2024 | | |
| Pathogenicity | Hydroxyproline increases inflammation and Uropathogenic E. coli (UPEC) infection in female rats. | Kumar P, Yang Z, Fatima H, Mitchell T. | Sci Rep | 10.1038/s41598-024-73246-6 | 2024 | |
| Polyvalent Bacterial Lysate with Potential Use to Treatment and Control of Recurrent Urinary Tract Infections. | Acevedo-Monroy SE, Rocha-Ramirez LM, Martinez Gomez D, Basurto-Alcantara FJ, Medina-Contreras O, Hernandez-Chinas U, Quinones-Pena MA, Garcia-Sosa DI, Ramirez-Lezama J, Rodriguez-Garcia JA, Gonzalez-Villalobos E, Castro-Luna R, Martinez-Cristobal L, Eslava-Campos CA. | Int J Mol Sci | 10.3390/ijms25116157 | 2024 | | |
| Antibacterial and antibiofilm activities of iodinated hydrocarbons against Vibrio parahaemolyticus and Staphylococcus aureus. | Faleye OO, Faleye OS, Lee JH, Lee J. | Sci Rep | 10.1038/s41598-024-55479-7 | 2024 | | |
| Antifungal, anti-biofilm, and anti-hyphal properties of N-substituted phthalimide derivatives against Candida species. | Shaik S, Lee JH, Kim YG, Lee J. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1414618 | 2024 | | |
| Centella asiatica and Its Metabolite Asiatic Acid: Wound Healing Effects and Therapeutic Potential. | Diniz LRL, Calado LL, Duarte ABS, de Sousa DP. | Metabolites | 10.3390/metabo13020276 | 2023 | | |
| Gentamicin loaded niosomes against intracellular uropathogenic Escherichia coli strains | Forte J, Maurizi L, Fabiano M, Conte A, Conte M, Ammendolia M, D'Intino E, Catizone A, Gesualdi L, Rinaldi F, Carafa M, Marianecci C, Longhi C. | Sci Rep | 2024 | | ||
| The Antibiofilm Effects of Antimony Tin Oxide Nanoparticles against Polymicrobial Biofilms of Uropathogenic Escherichia coli and Staphylococcus aureus. | Park I, Jailani A, Lee JH, Ahmed B, Lee J. | Pharmaceutics | 10.3390/pharmaceutics15061679 | 2023 | | |
| Roles of OmpX, an Outer Membrane Protein, on Virulence and Flagellar Expression in Uropathogenic Escherichia coli. | Hirakawa H, Suzue K, Takita A, Kamitani W, Tomita H. | Infect Immun | 10.1128/iai.00721-20 | 2021 | | |
| Ursolic acid: biological functions and application in animal husbandry. | Liu G, Qin P, Cheng X, Wu L, Wang R, Gao W. | Front Vet Sci | 10.3389/fvets.2023.1251248 | 2023 | | |
| Antivirulence activities of retinoic acids against Staphylococcus aureus. | Park I, Lee JH, Ma JY, Tan Y, Lee J. | Front Microbiol | 10.3389/fmicb.2023.1224085 | 2023 | | |
| Photochemical inactivation as an alternative method to produce a whole-cell vaccine for uropathogenic Escherichia coli (UPEC). | Westcott MM, Morse AE, Troy G, Blevins M, Wierzba T, Sanders JW. | Microbiol Spectr | 10.1128/spectrum.03661-23 | 2024 | | |
| In Vitro and In Vivo Characterization of Tebipenem, an Oral Carbapenem. | Cotroneo N, Rubio A, Critchley IA, Pillar C, Pucci MJ. | Antimicrob Agents Chemother | 10.1128/aac.02240-19 | 2020 | | |
| Does Secondary Plant Metabolite Ursolic Acid Exhibit Antibacterial Activity against Uropathogenic Escherichia coli Living in Single- and Multispecies Biofilms? | Sycz Z, Wojnicz D, Tichaczek-Goska D. | Pharmaceutics | 10.3390/pharmaceutics14081691 | 2022 | | |
| Physicochemical and Functional Properties of Black Walnut and Sycamore Syrups. | McHugh O, Ayilaran E, DeBastiani A, Jung Y. | Foods | 10.3390/foods13172780 | 2024 | | |
| Antibiofilm Activities of Cinnamaldehyde Analogs against Uropathogenic Escherichia coli and Staphylococcus aureus. | Kim Y, Kim S, Cho KH, Lee JH, Lee J. | Int J Mol Sci | 10.3390/ijms23137225 | 2022 | | |
| Azithromycin-liposomes as a novel approach for localized therapy of cervicovaginal bacterial infections. | Vanic Z, Rukavina Z, Manner S, Fallarero A, Uzelac L, Kralj M, Amidzic Klaric D, Bogdanov A, Raffai T, Virok DP, Filipovic-Grcic J, Skalko-Basnet N. | Int J Nanomedicine | 10.2147/ijn.s211691 | 2019 | | |
| Effect of Ciprofloxacin-Loaded Niosomes on Escherichia coli and Staphylococcus aureus Biofilm Formation. | Maurizi L, Forte J, Ammendolia MG, Hanieh PN, Conte AL, Relucenti M, Donfrancesco O, Ricci C, Rinaldi F, Marianecci C, Carafa M, Longhi C. | Pharmaceutics | 10.3390/pharmaceutics14122662 | 2022 | | |
| Antimicrobial Peptide LCN2 Inhibited Uropathogenic Escherichia coli Infection in Bladder Cells in a High-Glucose Environment through JAK/STAT Signaling Pathway. | Chen PC, Ho CH, Fan CK, Liu SP, Cheng PC. | Int J Mol Sci | 10.3390/ijms232415763 | 2022 | | |
| The role of uropathogenic Escherichia coli adhesive molecules in inflammatory response- comparative study on immunocompetent hosts and kidney recipients. | Wojciuk B, Majewska K, Grygorcewicz B, Krukowska Z, Kwiatkowska E, Ciechanowski K, Dolegowska B. | PLoS One | 10.1371/journal.pone.0268243 | 2022 | | |
| Candida albicans enhances Staphylococcus aureus virulence by progressive generation of new phenotypes. | Arevalo-Jaimes BV, Torrents E. | Curr Res Microb Sci | 10.1016/j.crmicr.2024.100316 | 2024 | | |
| The Enhancement of the Photodynamic Therapy and Ciprofloxacin Activity against Uropathogenic Escherichia coli Strains by Polypodium vulgare Rhizome Aqueous Extract. | Tichaczek-Goska D, Glensk M, Wojnicz D. | Pathogens | 10.3390/pathogens10121544 | 2021 | | |
| Synthetic Phosphoethanolamine Cellobiose Promotes Escherichia coli Biofilm Formation and Congo Red Binding. | Nguyen JM, Moore RE, Spicer SK, Gaddy JA, Townsend SD. | Chembiochem | 10.1002/cbic.202000869 | 2021 | | |
| The inactivation of tolC sensitizes Escherichia coli to perturbations in lipopolysaccharide transport. | Zhu S, Alexander MK, Paiva TO, Rachwalski K, Miu A, Xu Y, Verma V, Reichelt M, Dufrene YF, Brown ED, Cox G. | iScience | 10.1016/j.isci.2024.109592 | 2024 | | |
| Accessing the In Vivo Efficiency of Clinically Isolated Phages against Uropathogenic and Invasive Biofilm-Forming Escherichia coli Strains for Phage Therapy. | Sanmukh SG, Admella J, Moya-Anderico L, Feher T, Arevalo-Jaimes BV, Blanco-Cabra N, Torrents E. | Cells | 10.3390/cells12030344 | 2023 | | |
| A metabolomics pipeline highlights microbial metabolism in bloodstream infections. | Mayers JR, Varon J, Zhou RR, Daniel-Ivad M, Beaulieu C, Bhosle A, Glasser NR, Lichtenauer FM, Ng J, Vera MP, Huttenhower C, Perrella MA, Clish CB, Zhao SD, Baron RM, Balskus EP. | Cell | 10.1016/j.cell.2024.05.035 | 2024 | | |
| RNase 7 Inhibits Uropathogenic Escherichia coli-Induced Inflammation in Bladder Cells under a High-Glucose Environment by Regulating the JAK/STAT Signaling Pathway. | Ho CH, Liao PW, Fan CK, Liu SP, Cheng PC. | Int J Mol Sci | 10.3390/ijms23095156 | 2022 | | |
| Pathogenicity | Ligilactobacillus salivarius CNCM I-4866, a potential probiotic candidate, shows anti-inflammatory properties in vitro and in vivo. | Carbonne C, Chadi S, Kropp C, Molimard L, Chain F, Langella P, Martin R. | Front Microbiol | 10.3389/fmicb.2023.1270974 | 2023 | |
| Antimicrobial and antibiofilm activity of human recombinant H1 histones against bacterial infections. | Arevalo-Jaimes BV, Salinas-Pena M, Ponte I, Jordan A, Roque A, Torrents E. | mSystems | 10.1128/msystems.00704-24 | 2024 | | |
| Anti-biofilm activity of caffeine against uropathogenic E. coli is mediated by curli biogenesis. | Rathi B, Gupta S, Kumar P, Kesarwani V, Dhanda RS, Kushwaha SK, Yadav M. | Sci Rep | 10.1038/s41598-022-23647-2 | 2022 | | |
| Insulin Downregulated the Infection of Uropathogenic Escherichia coli (UPEC) in Bladder Cells in a High-Glucose Environment through JAK/STAT Signaling Pathway. | Ho CH, Liu SP, Fan CK, Tzou KY, Wu CC, Cheng PC. | Microorganisms | 10.3390/microorganisms9122421 | 2021 | | |
| Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids. | Pradhan S, Weiss AA. | mBio | 10.1128/mbio.01470-20 | 2020 | | |
| Antibiofilm and Antimicrobial Activities of Chloroindoles Against Uropathogenic Escherichia coli. | Boya BR, Lee JH, Lee J. | Front Microbiol | 10.3389/fmicb.2022.872943 | 2022 | | |
| Comparative Characteristics and Pathogenic Potential of Escherichia coli Isolates Originating from Poultry Farms, Retail Meat, and Human Urinary Tract Infection. | Sarowska J, Olszak T, Jama-Kmiecik A, Frej-Madrzak M, Futoma-Koloch B, Gawel A, Drulis-Kawa Z, Choroszy-Krol I. | Life (Basel) | 10.3390/life12060845 | 2022 | | |
| Phylogeny | Antibiotic resistance, virulence, and phylogenetic analysis of Escherichia coli strains isolated from free-living birds in human habitats. | Rybak B, Krawczyk B, Furmanek-Blaszk B, Wysocka M, Fordon M, Ziolkowski P, Meissner W, Stepniewska K, Sikorska K. | PLoS One | 10.1371/journal.pone.0262236 | 2022 | |
| Metabolism | Effect of dithiocyano-methane on hexose monophosphate pathway in the respiratory metabolism of Escherichia coli. | Chen Y, Ke W, Qin H, Chen S, Qin L, Yang Y, Yu H, Tan Y. | AMB Express | 10.1186/s13568-020-01142-z | 2020 | |
| Targeting of Uropathogenic Escherichia coli papG gene using CRISPR-dot nanocomplex reduced virulence of UPEC. | Gupta S, Kumar P, Rathi B, Verma V, Dhanda RS, Devi P, Yadav M. | Sci Rep | 10.1038/s41598-021-97224-4 | 2021 | | |
| Is it Worth Combining Solidago virgaurea Extract and Antibiotics against Uropathogenic Escherichia coli rods? An In Vitro Model Study. | Wojnicz D, Tichaczek-Goska D, Glensk M, Hendrich AB. | Pharmaceutics | 10.3390/pharmaceutics13040573 | 2021 | | |
| Pathogenicity | Oxalate Alters Cellular Bioenergetics, Redox Homeostasis, Antibacterial Response, and Immune Response in Macrophages. | Kumar P, Saini K, Saini V, Mitchell T. | Front Immunol | 10.3389/fimmu.2021.694865 | 2021 | |
| Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment. | Zulk JJ, Clark JR, Ottinger S, Ballard MB, Mejia ME, Mercado-Evans V, Heckmann ER, Sanchez BC, Trautner BW, Maresso AW, Patras KA. | mSphere | 10.1128/msphere.00345-22 | 2022 | | |
| Staphylococcus aureus induced trained immunity in macrophages confers heterologous protection against gram-negative bacterial infection. | Carlile SR, Cahill SC, O'Brien EC, Neto NGB, Monaghan MG, McLoughlin RM. | iScience | 10.1016/j.isci.2024.111284 | 2024 | | |
| Liposomes-Based Drug Delivery Systems of Anti-Biofilm Agents to Combat Bacterial Biofilm Formation. | Makhlouf Z, Ali AA, Al-Sayah MH. | Antibiotics (Basel) | 10.3390/antibiotics12050875 | 2023 | | |
| Metabolism | Flavones as Quorum Sensing Inhibitors Identified by a Newly Optimized Screening Platform Using Chromobacterium violaceum as Reporter Bacteria. | Skogman ME, Kanerva S, Manner S, Vuorela PM, Fallarero A. | Molecules | 10.3390/molecules21091211 | 2016 | |
| Neutrophil extracellular traps formation and clearance is enhanced in fever and attenuated in hypothermia. | Janko J, Becka E, Kmetova K, Hudecova L, Konecna B, Celec P, Bajaj-Elliott M, Pastorek M. | Front Immunol | 10.3389/fimmu.2023.1257422 | 2023 | | |
| Interspecies Horizontal Transfer and Specific Integration of the Mosquitocidal Toxin-Encoding Plasmid pTAND672-2 from Bacillus thuringiensis subsp. israelensis to Lysinibacillus sphaericus. | Geng P, Zhao P, Wan X, Mahillon J, Hu Y, Gong Y, Hu X. | Appl Environ Microbiol | 10.1128/aem.01652-22 | 2023 | | |
| HSPA8 regulates anti-bacterial autophagy through liquid-liquid phase separation. | Miao C, Zhang Y, Yu M, Wei Y, Dong C, Pei G, Xiao Y, Yang J, Yao Z, Wang Q. | Autophagy | 10.1080/15548627.2023.2223468 | 2023 | | |
| Pathogenicity | Drug-Free Enzyme-Based Bactericidal Nanomotors against Pathogenic Bacteria. | Vilela D, Blanco-Cabra N, Eguskiza A, Hortelao AC, Torrents E, Sanchez S. | ACS Appl Mater Interfaces | 10.1021/acsami.1c00986 | 2021 | |
| Insightful Improvement in the Design of Potent Uropathogenic E. coli FimH Antagonists. | Mousavifar L, Sarshar M, Bridot C, Scribano D, Ambrosi C, Palamara AT, Vergoten G, Roubinet B, Landemarre L, Bouckaert J, Roy R. | Pharmaceutics | 10.3390/pharmaceutics15020527 | 2023 | | |
| Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli. | Aedo SJ, Tang J, Brynildsen MP. | Antimicrob Agents Chemother | 10.1128/aac.00858-20 | 2021 | | |
| Enzymology | Physical Extraction and Fast Protein Liquid Chromatography for Purifying Flagella Filament From Uropathogenic Escherichia coli for Immune Assay. | Acharya D, Sullivan MJ, Duell BL, Eveno T, Schembri MA, Ulett GC. | Front Cell Infect Microbiol | 10.3389/fcimb.2019.00118 | 2019 | |
| Plasma-induced nanostructured metallic silver surfaces: study of bacteriophobic effect to avoid bacterial adhesion on medical devices. | Garcia-Bonillo C, Texido R, Gilabert-Porres J, Borros S. | Heliyon | 10.1016/j.heliyon.2022.e10842 | 2022 | | |
| Phage Display-Derived Peptides and Antibodies for Bacterial Infectious Diseases Therapy and Diagnosis. | Zhao H, Nie D, Hu Y, Chen Z, Hou Z, Li M, Xue X. | Molecules | 10.3390/molecules28062621 | 2023 | | |
| Widespread occurrence of bacterial human virulence determinants in soil and freshwater environments. | Soborg DA, Hendriksen NB, Kilian M, Kroer N. | Appl Environ Microbiol | 10.1128/aem.01633-13 | 2013 | | |
| Rapid Antimicrobial Susceptibility Testing of Patient Urine Samples Using Large Volume Free-Solution Light Scattering Microscopy. | Mo M, Yang Y, Zhang F, Jing W, Iriya R, Popovich J, Wang S, Grys T, Haydel SE, Tao N. | Anal Chem | 10.1021/acs.analchem.9b02174 | 2019 | | |
| An immunoresponsive three-dimensional urine-tolerant human urothelial model to study urinary tract infection. | Jafari NV, Rohn JL. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1128132 | 2023 | | |
| Involvement of NLRP3 and NLRC4 Inflammasome in Uropathogenic E. coli Mediated Urinary Tract Infections. | Verma V, Gupta S, Kumar P, Yadav S, Dhanda RS, Gaind R, Arora R, Frimodt-Moller N, Yadav M. | Front Microbiol | 10.3389/fmicb.2019.02020 | 2019 | | |
| The Tol-Pal System of Uropathogenic Escherichia coli Is Responsible for Optimal Internalization Into and Aggregation Within Bladder Epithelial Cells, Colonization of the Urinary Tract of Mice, and Bacterial Motility. | Hirakawa H, Suzue K, Kurabayashi K, Tomita H. | Front Microbiol | 10.3389/fmicb.2019.01827 | 2019 | | |
| Enzymology | Selective Uropathogenic E. coli Detection Using Crossed Surface-Relief Gratings. | Nair S, Gomez-Cruz J, Manjarrez-Hernandez A, Ascanio G, Sabat RG, Escobedo C. | Sensors (Basel) | 10.3390/s18113634 | 2018 | |
| Axiom Microbiome Array, the next generation microarray for high-throughput pathogen and microbiome analysis. | Thissen JB, Be NA, McLoughlin K, Gardner S, Rack PG, Shapero MH, Rowland RRR, Slezak T, Jaing CJ. | PLoS One | 10.1371/journal.pone.0212045 | 2019 | | |
| Anti-Planktonic and Anti-Biofilm Properties of Pentacyclic Triterpenes-Asiatic Acid and Ursolic Acid as Promising Antibacterial Future Pharmaceuticals. | Sycz Z, Tichaczek-Goska D, Wojnicz D. | Biomolecules | 10.3390/biom12010098 | 2022 | | |
| Metabolism | Inhibition of Escherichia coli Lipoprotein Diacylglyceryl Transferase Is Insensitive to Resistance Caused by Deletion of Braun's Lipoprotein. | Diao J, Komura R, Sano T, Pantua H, Storek KM, Inaba H, Ogawa H, Noland CL, Peng Y, Gloor SL, Yan D, Kang J, Katakam AK, Volny M, Liu P, Nickerson NN, Sandoval W, Austin CD, Murray J, Rutherford ST, Reichelt M, Xu Y, Xu M, Yanagida H, Nishikawa J, Reid PC, Cunningham CN, Kapadia SB. | J Bacteriol | 10.1128/jb.00149-21 | 2021 | |
| Metabolism | Augmentation of Urinary Lactoferrin Enhances Host Innate Immune Clearance of Uropathogenic Escherichia coli. | Patras KA, Ha AD, Rooholfada E, Olson J, Ramachandra Rao SP, Lin AE, Nizet V. | J Innate Immun | 10.1159/000499342 | 2019 | |
| An evaluation of the virulence and adherence properties of avian pathogenic Escherichia coli. | LeStrange K, Markland SM, Hoover DG, Sharma M, Kniel KE. | One Health | 10.1016/j.onehlt.2017.08.001 | 2017 | | |
| Potentiating the Activity of Nisin against Escherichia coli. | Zhou L, van Heel AJ, Montalban-Lopez M, Kuipers OP. | Front Cell Dev Biol | 10.3389/fcell.2016.00007 | 2016 | | |
| Quantitation of ethanol in UTI assay for volatile organic compound detection by electronic nose using the validated headspace GC-MS method. | Than N, Chik Z, Bowers A, Bozano L, Adebiyi A. | PLoS One | 10.1371/journal.pone.0275517 | 2022 | | |
| Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in Acinetobacter baumannii. | Huang KJ, Pantua H, Diao J, Skippington E, Volny M, Sandoval W, Tiku V, Peng Y, Sagolla M, Yan D, Kang J, Katakam AK, Michaelian N, Reichelt M, Tan MW, Austin CD, Xu M, Hanan E, Kapadia SB. | Proc Natl Acad Sci U S A | 10.1073/pnas.2123117119 | 2022 | | |
| Pathogenicity | A peptide derived from phage display library exhibits antibacterial activity against E. coli and Pseudomonas aeruginosa. | Sainath Rao S, Mohan KV, Atreya CD. | PLoS One | 10.1371/journal.pone.0056081 | 2013 | |
| Pathogenicity | Type 1 piliated uropathogenic Escherichia coli hijack the host immune response by binding to CD14. | Tomasek K, Leithner A, Glatzova I, Lukesch MS, Guet CC, Sixt M. | Elife | 10.7554/elife.78995 | 2022 | |
| Enzymology | Features of urinary Escherichia coli isolated from children with complicated and uncomplicated urinary tract infections in Mexico. | Luna-Pineda VM, Ochoa SA, Cruz-Cordova A, Cazares-Dominguez V, Reyes-Grajeda JP, Flores-Oropeza MA, Arellano-Galindo J, Hernandez-Castro R, Flores-Encarnacion M, Ramirez-Vargas A, Flores-Garcia HJ, Moreno-Fierros L, Xicohtencatl-Cortes J. | PLoS One | 10.1371/journal.pone.0204934 | 2018 | |
| Discovery of a Pseudomonas aeruginosa-specific small molecule targeting outer membrane protein OprH-LPS interaction by a multiplexed screen. | Poulsen BE, Warrier T, Barkho S, Bagnall J, Romano KP, White T, Yu X, Kawate T, Nguyen PH, Raines K, Ferrara K, Golas AL, FitzGerald M, Boeszoermenyi A, Kaushik V, Serrano-Wu M, Shoresh N, Hung DT. | Cell Chem Biol | 10.1016/j.chembiol.2024.12.001 | 2025 | | |
| Pathogenicity | Subinhibitory Concentrations of Allicin Decrease Uropathogenic Escherichia coli (UPEC) Biofilm Formation, Adhesion Ability, and Swimming Motility. | Yang X, Sha K, Xu G, Tian H, Wang X, Chen S, Wang Y, Li J, Chen J, Huang N. | Int J Mol Sci | 10.3390/ijms17070979 | 2016 | |
| Fur Represses Adhesion to, Invasion of, and Intracellular Bacterial Community Formation within Bladder Epithelial Cells and Motility in Uropathogenic Escherichia coli. | Kurabayashi K, Agata T, Asano H, Tomita H, Hirakawa H. | Infect Immun | 10.1128/iai.00369-16 | 2016 | | |
| Metabolism | Rapid Bladder Interleukin-10 Synthesis in Response to Uropathogenic Escherichia coli Is Part of a Defense Strategy Triggered by the Major Bacterial Flagellar Filament FliC and Contingent on TLR5. | Acharya D, Sullivan MJ, Duell BL, Goh KGK, Katupitiya L, Gosling D, Chamoun MN, Kakkanat A, Chattopadhyay D, Crowley M, Crossman DK, Schembri MA, Ulett GC. | mSphere | 10.1128/msphere.00545-19 | 2019 | |
| Inhibiting Bacterial Drug Efflux Pumps via Phyto-Therapeutics to Combat Threatening Antimicrobial Resistance. | Shriram V, Khare T, Bhagwat R, Shukla R, Kumar V. | Front Microbiol | 10.3389/fmicb.2018.02990 | 2018 | | |
| Pathogenicity | NAD+ prevents septic shock-induced death by non-canonical inflammasome blockade and IL-10 cytokine production in macrophages. | Iske J, El Fatimy R, Nian Y, Ghouzlani A, Eskandari SK, Cetina Biefer HR, Vasudevan A, Elkhal A, Elkhal A. | Elife | 10.7554/elife.88686 | 2024 | |
| Spectrophotometric photodynamic detection involving extracorporeal treatment with hexaminolevulinate for bladder cancer cells in voided urine. | Nakai Y, Ozawa T, Mizuno F, Onishi S, Owari T, Hori S, Morizawa Y, Tatsumi Y, Miyake M, Tanaka N, Tsuruta D, Fujimoto K. | J Cancer Res Clin Oncol | 10.1007/s00432-017-2476-5 | 2017 | | |
| Pathogenicity | Effects of Aronia melanocarpa constituents on biofilm formation of Escherichia coli and Bacillus cereus. | Braunlich M, Okstad OA, Slimestad R, Wangensteen H, Malterud KE, Barsett H. | Molecules | 10.3390/molecules181214989 | 2013 | |
| Pathogenicity | Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients. | Daisley BA, Chanyi RM, Abdur-Rashid K, Al KF, Gibbons S, Chmiel JA, Wilcox H, Reid G, Anderson A, Dewar M, Nair SM, Chin J, Burton JP. | Nat Commun | 10.1038/s41467-020-18649-5 | 2020 | |
| Proanthocyanidin Interferes with Intrinsic Antibiotic Resistance Mechanisms of Gram-Negative Bacteria. | Maisuria VB, Okshevsky M, Deziel E, Tufenkji N. | Adv Sci (Weinh) | 10.1002/advs.201802333 | 2019 | | |
| Metabolism | Testosterone suppresses uropathogenic Escherichia coli invasion and colonization within prostate cells and inhibits inflammatory responses through JAK/STAT-1 signaling pathway. | Ho CH, Fan CK, Yu HJ, Wu CC, Chen KC, Liu SP, Cheng PC. | PLoS One | 10.1371/journal.pone.0180244 | 2017 | |
| Metabolism | Disrupting Gram-Negative Bacterial Outer Membrane Biosynthesis through Inhibition of the Lipopolysaccharide Transporter MsbA. | Alexander MK, Miu A, Oh A, Reichelt M, Ho H, Chalouni C, Labadie S, Wang L, Liang J, Nickerson NN, Hu H, Yu L, Du M, Yan D, Park S, Kim J, Xu M, Sellers BD, Purkey HE, Skelton NJ, Koehler MFT, Payandeh J, Verma V, Xu Y, Koth CM, Nishiyama M. | Antimicrob Agents Chemother | 10.1128/aac.01142-18 | 2018 | |
| Metabolism | dsdA Does Not Affect Colonization of the Murine Urinary Tract by Escherichia coli CFT073. | Hryckowian AJ, Baisa GA, Schwartz KJ, Welch RA. | PLoS One | 10.1371/journal.pone.0138121 | 2015 | |
| Metabolism | Investigating the physiological roles of low-efficiency D-mannonate and D-gluconate dehydratases in the enolase superfamily: pathways for the catabolism of L-gulonate and L-idonate. | Wichelecki DJ, Vendiola JA, Jones AM, Al-Obaidi N, Almo SC, Gerlt JA. | Biochemistry | 10.1021/bi500837w | 2014 | |
| Review on Plant-Based Management in Combating Antimicrobial Resistance - Mechanistic Perspective. | Arip M, Selvaraja M, R M, Tan LF, Leong MY, Tan PL, Yap VL, Chinnapan S, Tat NC, Abdullah M, K D, Jubair N. | Front Pharmacol | 10.3389/fphar.2022.879495 | 2022 | | |
| Pathogenicity | Pentacyclic triterpenes combined with ciprofloxacin help to eradicate the biofilm formed in vitro by Escherichia coli. | Wojnicz D, Tichaczek-Goska D, Kicia M. | Indian J Med Res | 10.4103/0971-5916.156631 | 2015 | |
| Human milk oligosaccharides inhibit growth of group B Streptococcus. | Lin AE, Autran CA, Szyszka A, Escajadillo T, Huang M, Godula K, Prudden AR, Boons GJ, Lewis AL, Doran KS, Nizet V, Bode L. | J Biol Chem | 10.1074/jbc.m117.789974 | 2017 | | |
| Metabolism | Cell-specific qRT-PCR of renal epithelial cells reveals a novel innate immune signature in murine collecting duct. | Saxena V, Hains DS, Ketz J, Chanley M, Spencer JD, Becknell B, Pierce KR, Nelson RD, Purkerson JM, Schwartz GJ, Schwaderer AL. | Am J Physiol Renal Physiol | 10.1152/ajprenal.00512.2016 | 2018 | |
| Metabolism | Peptidoglycan Association of Murein Lipoprotein Is Required for KpsD-Dependent Group 2 Capsular Polysaccharide Expression and Serum Resistance in a Uropathogenic Escherichia coli Isolate. | Diao J, Bouwman C, Yan D, Kang J, Katakam AK, Liu P, Pantua H, Abbas AR, Nickerson NN, Austin C, Reichelt M, Sandoval W, Xu M, Whitfield C, Kapadia SB. | mBio | 10.1128/mbio.00603-17 | 2017 | |
| Metabolism | Extracellular overexpression of recombinant Thermobifida fusca cutinase by alpha-hemolysin secretion system in E. coli BL21(DE3). | Su L, Chen S, Yi L, Woodard RW, Chen J, Wu J. | Microb Cell Fact | 10.1186/1475-2859-11-8 | 2012 | |
| Pathogenicity | Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity. | Lin AE, Autran CA, Espanola SD, Bode L, Nizet V. | J Infect Dis | 10.1093/infdis/jit464 | 2014 | |
| Pathogenicity | Inhibition of Escherichia coli CFT073 fliC expression and motility by cranberry materials. | Hidalgo G, Chan M, Tufenkji N. | Appl Environ Microbiol | 10.1128/aem.05561-11 | 2011 | |
| Metallohelices that kill Gram-negative pathogens using intracellular antimicrobial peptide pathways. | Simpson DH, Hapeshi A, Rogers NJ, Brabec V, Clarkson GJ, Fox DJ, Hrabina O, Kay GL, King AK, Malina J, Millard AD, Moat J, Roper DI, Song H, Waterfield NR, Scott P. | Chem Sci | 10.1039/c9sc03532j | 2019 | | |
| Role of sigma E-regulated genes in Escherichia coli uropathogenesis. | Redford P, Welch RA. | Infect Immun | 10.1128/iai.01984-05 | 2006 | | |
| Metabolism | Human bladder uroepithelial cells synergize with monocytes to promote IL-10 synthesis and other cytokine responses to uropathogenic Escherichia coli. | Duell BL, Carey AJ, Dando SJ, Schembri MA, Ulett GC. | PLoS One | 10.1371/journal.pone.0078013 | 2013 | |
| Metabolism | Oral consumption of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic Escherichia coli. | Tao Y, Pinzon-Arango PA, Howell AB, Camesano TA. | J Med Food | 10.1089/jmf.2010.0154 | 2011 | |
| In vitro studies of the antibacterial activity of Copaifera spp. oleoresins, sodium hypochlorite, and peracetic acid against clinical and environmental isolates recovered from a hemodialysis unit. | Vieira RGL, Moraes TDS, Silva LO, Bianchi TC, Veneziani RCS, Ambrosio SR, Bastos JK, Pires RH, Martins CHG. | Antimicrob Resist Infect Control | 10.1186/s13756-018-0307-3 | 2018 | | |
| Host Cathelicidin Exacerbates Group B Streptococcus Urinary Tract Infection. | Patras KA, Coady A, Babu P, Shing SR, Ha AD, Rooholfada E, Brandt SL, Geriak M, Gallo RL, Nizet V. | mSphere | 10.1128/msphere.00932-19 | 2020 | | |
| Folding of a bacterial integral outer membrane protein is initiated in the periplasm. | Sikdar R, Peterson JH, Anderson DE, Bernstein HD. | Nat Commun | 10.1038/s41467-017-01246-4 | 2017 | | |
| Metabolism | Computational and experimental analysis of the secretome of Methylococcus capsulatus (Bath). | Indrelid S, Mathiesen G, Jacobsen M, Lea T, Kleiveland CR. | PLoS One | 10.1371/journal.pone.0114476 | 2014 | |
| Pathogenicity | Polyphenolic extract from maple syrup potentiates antibiotic susceptibility and reduces biofilm formation of pathogenic bacteria. | Maisuria VB, Hosseinidoust Z, Tufenkji N. | Appl Environ Microbiol | 10.1128/aem.00239-15 | 2015 | |
| Genetics | Investigating the global genomic diversity of Escherichia coli using a multi-genome DNA microarray platform with novel gene prediction strategies. | Jackson SA, Patel IR, Barnaba T, LeClerc JE, Cebula TA. | BMC Genomics | 10.1186/1471-2164-12-349 | 2011 | |
| Metabolism | Role of Hypoxia Inducible Factor-1alpha (HIF-1alpha) in Innate Defense against Uropathogenic Escherichia coli Infection. | Lin AE, Beasley FC, Olson J, Keller N, Shalwitz RA, Hannan TJ, Hultgren SJ, Nizet V. | PLoS Pathog | 10.1371/journal.ppat.1004818 | 2015 | |
| Pathogenicity | Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection. | Tan CK, Carey AJ, Cui X, Webb RI, Ipe D, Crowley M, Cripps AW, Benjamin WH, Ulett KB, Schembri MA, Ulett GC. | Infect Immun | 10.1128/iai.00023-12 | 2012 | |
| Metabolism | DsdX is the second D-serine transporter in uropathogenic Escherichia coli clinical isolate CFT073. | Anfora AT, Welch RA. | J Bacteriol | 10.1128/jb.00634-06 | 2006 | |
| Metabolism | alpha-Intercalated cells defend the urinary system from bacterial infection. | Paragas N, Kulkarni R, Werth M, Schmidt-Ott KM, Forster C, Deng R, Zhang Q, Singer E, Klose AD, Shen TH, Francis KP, Ray S, Vijayakumar S, Seward S, Bovino ME, Xu K, Takabe Y, Amaral FE, Mohan S, Wax R, Corbin K, Sanna-Cherchi S, Mori K, Johnson L, Nickolas T, D'Agati V, Lin CS, Qiu A, Al-Awqati Q, Ratner AJ, Barasch J. | J Clin Invest | 10.1172/jci71630 | 2014 | |
| Improving the sensitivity and specificity of gene expression analysis in highly related organisms through the use of electronic masks. | Nagpal S, Karaman MW, Timmerman MM, Ho VV, Pike BL, Hacia JG. | Nucleic Acids Res | 10.1093/nar/gnh048 | 2004 | | |
| Metabolism | Dissecting the bacterial type VI secretion system by a genome wide in silico analysis: what can be learned from available microbial genomic resources? | Boyer F, Fichant G, Berthod J, Vandenbrouck Y, Attree I. | BMC Genomics | 10.1186/1471-2164-10-104 | 2009 | |
How to cite
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive131713.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain dataIsabel Schober, Julia Koblitz, Joaquim Sardà Carbasse, Christian Ebeling, Marvin Leon Schmidt, Adam Podstawka, Rohit Gupta, Vinodh Ilangovan, Javad Chamanara, Jörg Overmann, Lorenz Christian Reimer
Nucleic Acids Research; database issue 2025.
License